Table 4

Effect on (−)U50,488H-stimulated [35S]GTPγS binding and [3H]diprenorphine binding to the κ receptor of 4-h pretreatment with 0.1 μM (−)U50,488H, 1 μM (+)U50,488H, 1 μM naloxone and 0.1 μM (−)U50,488H + 1 μM naloxone, and 4 h of 0.1 μM (−)U50,488H followed by 24-h recovery

[35S]GTPγS binding[3H]Diprenorphine binding
EC50Maximal bindingKdBmax
nM fmol/mg protein nM fmol/mg protein
Control3.8  ± 0.5191  ± 30.16  ± 0.021217  ± 48
(−)U50,488H, 0.1 μM9.2  ± 1.34-a 109  ± 64-a 0.20  ± 0.01858  ± 294-a
(+)U50,488H, 1 μM2.7  ± 0.7204  ± 60.14  ± 0.011158  ± 21
Naloxone, 10 μM3.2  ± 1.2193  ± 100.21  ± 0.021166  ± 36
(−)U50,488H, 0.1 μM + Naloxone, 10 μM3.3  ± 1.1179  ± 70.23  ± 0.011283  ± 36
(−)U50,488H, 0.1 μM + 24-h recovery3.4  ± 1.3189  ± 80.24  ± 0.031282  ± 25

CHO-hkor cells were subjected to various treatments as indicated and washed; the (−)U50,488H-induced increases in [35S]GTPγS binding and [3H]diprenorphine binding to the receptor were conducted as described under “Materials and Methods.” Each datum represents mean ± S.E.M. of three to six experiments. Data were analyzed by analysis of variance followed by the SheffeF-test.

  • 4-a P < .05 compared with the control.